Racial and ethnic disparities, however, persisted for various cancers, including prostate, male lung and bronchus, and female colorectal cancer.
The authors say that screening based on individual life expectancy, rather than age, may improve screening selection and value.
The incidence decreased significantly for 19 of 22 cancer types, deviating from stable year-over-year changes pre-COVID-19.
Fewer than half of those with an unsatisfactory FIT completed a subsequent test within 15 months.
Greater racial and geographic disparities in cancer mortality were seen for those younger than 65 years versus 65 years of age or older.
The meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy.
Responses are moderately understandable, not readily actionable, and written at the college reading level.
Single-site cancer screening could save an additional 3.2 million to 5.1 million life-years with perfect adherence.
Exposures to fine particulate matter and nitrogen dioxide were associated with increased risks for colorectal and prostate cancer in older adults.
However, some increased risk seen for lung cancer and smoking-related cancers
Please login or register first to view this content.
Login Register
